When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MNTA - Momenta's nipocalimab nabs Rare Pediatric Disease tag for anemia in newborns
Momenta Pharmaceuticals Inc.
The FDA has signed off on Rare Pediatric Disease designation for Momenta Pharmaceuticals' (NASDAQ:MNTA) nipocalimab for the prevention of hemolytic disease of the fetus and newborn, a rare disorder in babies in which red blood cells break down at a fast rate, a condition called erythroblastosis fetalis, caused by incompatibility between maternal and fetal blood groups. It occurs in 3K - 8K U.S. pregnancies each year.
More news on: Momenta Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,